Andrew Gabrielson

Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC

Andrew Gabrielson, Yunan Wu, Hongkun Wang et al. · Cancer Immunology Research · 2016 · 312 citations · Full text

T-regulatory Cell, Immunology, Immunoediting +17

Proposed Changes to the 2021 Residency Application Process in the Wake of COVID-19

Andrew Gabrielson, Jaden R. Kohn, Hayley T. Sparks et al. · Academic Medicine · 2020 · 69 citations · Full text

Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer

Zheng Wu, Andrew Gabrielson, Jimmy J. Hwang et al. · Cancer Chemotherapy and Pharmacology · 2015 · 46 citations

Second-line Treatment, Pancreatic Cancer, Gastrointestinal Oncology +8

Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma

Andrew Gabrielson, Anteneh Tesfaye, John L. Marshall et al. · Cancer Chemotherapy and Pharmacology · 2015 · 40 citations · Full text

A Phase 2 Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guérin‒Naïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder

Sunil Patel, Andrew Gabrielson, Sin Chan et al. · The Journal of Urology · 2024 · 30 citations